Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Home
Faculty
Departments
Grants
Publications
Prizes
Search by expertise, name or affiliation
Is 'off-protocol' chemotherapy for androgen-independent carcinoma of prostate warranted?
S. Mani
, N. J. Vogelzang
Research output
:
Contribution to journal
›
Article
›
peer-review
12
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Is 'off-protocol' chemotherapy for androgen-independent carcinoma of prostate warranted?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Androgens
100%
Prostate
91%
Carcinoma
72%
Drug Therapy
64%
Mitoxantrone
47%
Cytotoxins
40%
Patient Preference
40%
Prednisone
37%
Cyclophosphamide
33%
Physicians
23%
Therapeutics
17%